enGene Holdings Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
CEORonald Harold Wilfred Cooper
CEORonald Harold Wilfred Cooper
Employees57
Employees57
HeadquartersSaint-Laurent, Québec
HeadquartersSaint-Laurent, Québec
Founded2023
Founded2023
Employees57
Employees57
ENGN Key Statistics
Market cap520.50M
Market cap520.50M
Price-Earnings ratio-4.26
Price-Earnings ratio-4.26
Dividend yield—
Dividend yield—
Average volume348.95K
Average volume348.95K
High today$8.27
High today$8.27
Low today$7.88
Low today$7.88
Open price$8.27
Open price$8.27
Volume188.79K
Volume188.79K
52 Week high$11.14
52 Week high$11.14
52 Week low$2.65
52 Week low$2.65
Stock Snapshot
The current enGene Holdings Inc.(ENGN) stock price is $8.07, with a market capitalization of 520.5M. The stock trades at a price-to-earnings (P/E) ratio of -4.26.
During the trading session on 2025-12-07, enGene Holdings Inc.(ENGN) shares reached a daily high of $8.27 and a low of $7.88. At a current price of $8.07, the stock is +2.4% higher than the low and still -2.4% under the high.
Trading activity shows a volume of 188.79K, compared to an average daily volume of 348.95K.
The stock's 52-week range extends from a low of $2.65 to a high of $11.14.
The stock's 52-week range extends from a low of $2.65 to a high of $11.14.
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%
People also own
Based on the portfolios of people who own ENGN. This list is generated using Robinhood data, and it’s not a recommendation.